Note 7 - Inventory (Details Textual) |
Dec. 31, 2020
USD ($)
|
---|---|
Inventory, Raw Materials, Gross, Total | $ 77,750 |
Inventory, Finished Goods, Gross, Total | 92,048 |
Process Development [Member] | |
Inventory, Raw Materials, Gross, Total | 11,000 |
Clinical Trials [Member] | |
Inventory, Finished Goods, Gross, Total | $ 39,000 |
X | ||||||||||
- Definition Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|